Streetbeat News

Products Services

SSYS

Stratasys has formed a Customer Advisory Board comprising industry leaders to promote the advancement of additive manufacturing for large-scale production. This initiative marks a significant step by Stratasys in engaging with industry experts to shape the future of 3D printing technologies.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 12:18 pm

COST

CVS

TGT

On CNBC's 'Halftime Report Final Trades,' CVS Health Corporation (CVS) was highlighted for its strong comeback amid Amazon Pharmacy's expansion. Costco (COST) was favored despite missing revenue estimates, showing a 5.7% year-over-year sales increase. Target (TGT) was recommended after reporting a revenue growth of 1.7% year-on-year, despite a decline in comparable sales. CVS reaffirmed its 2024 earnings guidance, while Amazon launched Same-Day Delivery in select areas.

Portfolio Pulse from Avi Kapoor

March 27, 2024 | 12:14 pm

CART

Instacart (NASDAQ:CART) has launched the Instacart Developer Platform (IDP), a new API program designed to integrate Instacart's online grocery platform functionalities into third-party websites and apps. This initiative aims to enhance digital experiences across various sectors by providing same-day fulfillment, access to a rich item catalog, and real-time inventory updates from local retailers. The platform is expected to benefit developers and companies in food, health, wellness, and lifestyle sectors by enabling seamless integration of grocery shopping into their digital offerings.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 12:10 pm

PACB

PacBio (NASDAQ:PACB) has been selected by the University of Tartu, host of Estonia's National Biobank, to sequence 10,000 whole human genomes using the Revio HiFi sequencing system. This initiative, funded by the European Commission and the Estonian government, aims to advance personalized medicine and contribute to the EU's 1+ Million Genomes initiative. The project will explore genetics related to various health conditions and responses to medications, with the potential to significantly impact healthcare research and innovation.

Portfolio Pulse from Happy Mohamed

March 27, 2024 | 12:10 pm

MDXG

The FDA issued a determination letter to MiMedx, indicating that Axiofill, the company's product, does not meet the regulatory classification requirements for a human cell, tissue, or cellular or tissue-based product (HCT/P).

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 12:09 pm

ALGS

Aligos Therapeutics, Inc. (NASDAQ:ALGS) announced its participation in the 33rd Annual Meeting of the APASL 2024 with presentations on ALG-055009 and ALG-000184 Phase 1 studies. ALG-055009 showed favorable effects in hyperlipidemic subjects, while ALG-000184 demonstrated potent antiviral activity in CHB patients. The company remains optimistic about the potential of these compounds in treating liver and viral diseases.

Portfolio Pulse from Happy Mohamed

March 27, 2024 | 12:07 pm

ACN

Accenture (NYSE:ACN) has invested in Sanctuary AI, a company developing AI-powered humanoid robots designed to work alongside humans in various industries. Sanctuary AI's robot, Phoenix, has demonstrated the ability to perform over 100 tasks with human-like dexterity. This investment is part of Accenture Ventures' Project Spotlight, aiming to bridge innovation gaps by connecting startups with Accenture's global client base. The move aligns with Accenture's vision of integrating human-centric technology in the workforce, as highlighted in their Technology Vision 2024 report.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 12:03 pm

SSNC

SS&C Technologies Holdings, Inc. (SSNC) has received full approval from the Financial Services Regulatory Authority to provide fund administration services within the Abu Dhabi Global Market. This approval allows SS&C to expand its services in the Middle East, potentially increasing its market share and revenue in the region.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 12:02 pm

MDGS

Medigus Ltd. (NASDAQ:MDGS), through its subsidiary Fuel Doctor Holdings, Inc., announced that its EV joint venture, Revoltz Ltd, has completed the first production batch of 50 PORTO micro-mobility electric vehicles. This marks a significant step in fulfilling a $2.7 million distribution agreement aimed at selling 150 vehicles in Israel and adjacent territories within the first year. The PORTO EV, designed for the last-mile delivery market, offers a 100 km range on a single charge and features an advanced tilting suspension mechanism for stability.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 12:02 pm

SVRE

SaverOne has signed an OEM agreement with IVECO to integrate its safety technology into IVECO's vehicles directly through their manufacturing line. This partnership aims to enhance vehicle safety by incorporating SaverOne's advanced safety solutions.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 12:01 pm